RealNano Completes Organic Electronics Project

The European RealNano has recently completed its multi-million euro project of integrating intelligent nano-characterization techniques and Artificial Intelligence methodologies to improve real-time properties, qualities, and functionalities of produced Organics Electronics devices.
 
H2020 RealNano has developed and integrated efficient and fast nano characterization tools and real time analysis methods into production processes and pilot lines. By doing this, production efficiencies have been improved by 90% while reducing waste, energy, and raw material requirements by 30%. 
 
The project created applications that contribute to the digital transformation of European industry and applications in the energy, automotive, transports, and agri-food (agrivoltaics) sectors. Flexible organic photovoltaics, OLEDs, and printed biosensors as well as the large-scale organic electronics printing industry were revolutionized by this project. 
 
Founded by HORIZON202 for 42 months (March 1, 2020- August 31, 2023) the project involved 12 companies and research centers from six European countries (Greece, Germany, Italy, France, Hungary, and the UK). Greece contributed a significant amount of participation in the project, as the LTFN Nanotechnology Laboratory of the Aristotle University of Thessaloniki, OET, BLNanobiomed, and the HOPE-A Association were all involved. 
 
LTFN Laboratory of Nanotechnology of the Aristotle University of Thessaloniki led the project and builds on four decades of experience in the field of Nanotechnology, Nanosciences and Organic Electronics, and will start the mass production of Organic Photovoltaics with OET.  
 
RealNano paves the way for efficient production of organic photovoltaics, which are integrated into a variety of products such as translucent curved solar roofs in cars and other means of transport. At the start of the pandemic RealNano adapted their project to the development of biosensors for COVID-19, and for the detection of cardiovascular diseases, which was recognized by the European Commission.